Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Spectrum Analysis × Thoracic × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Thoracic 1 Sarcoma 1 Other neoplasm 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Endocrine 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 384 Cisplatin 318 Pemetrexed 258 Paclitaxel 249 Docetaxel 206 Gemcitabine 200 Erlotinib Hydrochloride 199 Radiotherapy 147 Bevacizumab 144 pembrolizumab 131 Nivolumab 104 Etoposide 88 Vinorelbine 75 Gefitinib 74 durvalumab 55 Topotecan 55 atezolizumab 54 Cetuximab 54 Drug Therapy 47 Irinotecan 45 Ipilimumab 43 Radiosurgery 42 osimertinib 40 Afatinib 39 Albumin-Bound Paclitaxel 30 130-nm albumin-bound paclitaxel 30 Cyclophosphamide 29 Surgical Procedures, Operative 28 Taxes 27 Surveys and Questionnaires 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03356743 2018-05-04

Spectrum Analysis in Ex-vivo Human Lungs

University Health Network, Toronto

Phase NA Completed

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡